Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 229

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer

Open access
Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Scarpidis, U., Lin, Q.-Q., Terai, M., Bromley, R. L., Buetow, K., Apple, R. J., Burk, R. D.·2001·JNCI Journal of the National Cancer Institute

Abstract

There are substantial data demonstrating that human papillomaviruses (HPVs) are the sexually transmitted etiologic agents of cervical cancer (1). HPV type 16 (HPV16) is the most common HPV type detected in tumors, accounting for 50% of cancers and their precursors, called high-grade squamous intraepithelial lesions (HSILs) (2). Preliminary studies (3–16) have suggested that variants of HPV16 may show varying degrees of association with cervical neoplasia. This may partially explain why some HPV16 infections progress to HSIL or cancer, while others do not. If causal, these associations may be explained by differences in the transcriptional regulation of the virus by different variants, in the biologic activities of the proteins encoded by HPV16 variants (e.g., enhanced transforming abilities of E6/E7), or in the ability of the host to respond immunologically to specific viral epitopes encoded by variants. This last effect is likely to be mediated through human leukocyte antigen (HLA) presentation of viral antigens (17–21). Previous studies of viral variants and cervical neoplasia have relied on convenience samples, limiting their interpretation, while others have had small sample size.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/93.4.315

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 229

Metadata

Authors
Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Scarpidis, U., Lin, Q.-Q., Terai, M., Bromley, R. L., Buetow, K., Apple, R. J., & Burk, R. D.
Venue
JNCI Journal of the National Cancer Institute
Published
2001-02-21
Volume
93
Issue
4
Pages
315-318
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2169918603
Cited by
229
References
1
FWCI
7.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. https://app.cochat.ai/papers/10.1093/jnci/93.4.315
The paper
Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Scarpidis, U., Lin, Q.-Q., Terai, M., Bromley, R. L., Buetow, K., Apple, R. J., & Burk, R. D. (2001). Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/93.4.315

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.